Moreover, given that studies are increasingly recognizing the role of immune dysregulation and inflammation driven by chemokines such as CCL18 in the pathogenesis of Gaucher disease, CCR1 modulation could also be relevant for the Gaucher patients developing PD. Here, CCR1 is linked to Gaucher disease.